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PhagocytosisApocynin, a methoxy-substituted catechol (4-hydroxy-3-methoxyacetophenone), originally extracted from
the roots of Picrorhiza kurroa, has been extensively used as a non-toxic inhibitor of the multienzymatic
complex NADPH oxidase. We discovered that the analogous methoxy-substituted catechol, 4-Fluoro-2-
methoxyphenol (F-apocynin), in which the acetyl group present in apocynin was changed to a ﬂuorine atom,
was signiﬁcantly more potent as an inhibitor of NADPH oxidase activity, myeloperoxidase (MPO) chlorinating
activity and phagocytosis of microorganisms by neutrophils; it was also as potent as apocynin in inhibiting
tumor necrosis factor-alpha (TNFα) release by peripheral blood mononuclear cells. We attribute the
increased potency of F-apocynin to its increased lipophilicity, which could facilitate the passage of the drug
through the cell membrane. The inhibition ofMPO chlorination activity, phagocytosis and TNFα release shows
that apocynin and F-apocynin actions are not restricted to reactive oxygen species inhibition, but further
studies are needed to clarify if these mechanisms are related. Like apocynin, F-apocynin did not show cell
toxicity, and is a strong candidate for use in the treatment of inﬂammatory diseases.arrijo Coube, 14-01, Bauru, SP,
eida).
vier OA license.© 2011 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Reactive oxygen species play a central role in host defense by killing
microbes in phagocytic cells. NADPH oxidase is a multienzymatic
complex formed by cytochrome b558 linked to the membrane, three
cytosolic factors (p47phox, p67phox e p40phox) and the small GTPase
Rac2 (in neutrophils) or Rac1 (inmonocytes).When cells are activated
by stimuli like opsonized particles or phorbol myristate acetate, a
cascade of events is initiated that results in migration of the NADPH
oxidase cytosolic components to the membrane and the assembly of
the enzymatic complex that initiates O2− production (Cathcart, 2004;
Groemping and Rittinger, 2005; Ushio-Fukai, 2009), which, sponta-
neously or catalyzed by superoxide dismutase, dismutates to hydro-
gen peroxide. In this sequence, oxidant compounds like hydroxyl
radicals, singlet oxygen, ozone and hypochlorous acid can be
generated and constitute the microbicidal arsenal of phagocytes.
Hypochlorous acid (HOCl) is generated by chloride anion oxidation by
H2O2 via catalytic action of myeloperoxidase (MPO), which is also
released into the phagolysosome during cell activation (Hansson et al.,
2006; Klebanoff, 2005).However, excessive production of ROS is harmful to the adjacent
tissue and is involved in the genesis and/or progression of several
inﬂammatory diseases, including vascular diseases with an inﬂamma-
tory component (vasculitis, arteritis, atherosclerosis, hypertension and
myocardial infarction, for example). This fact has stimulated the
development of drugs targeting the NADPH oxidase system (Heumuller
et al., 2008; Jo et al., 2006; Sun et al., 2007). In the sameway, a growing
body of literature implicates MPO-derived HOCl in the progression of
inﬂammatory diseases, such as atherosclerosis, asthma, rheumatoid
arthritis, cystic ﬁbrosis, kidney diseases and some cancers (Malle et al.,
2007). Increasing efforts have been devoted towards the development
of a therapeutically useful myeloperoxidase inhibitor.
Apocynin is a methoxy-substituted catechol (4-hydroxy-3-meth-
oxyacetophenone), originally extracted from the roots of Picrorhiza
kurroa, from the Himalayas, that has demonstrated anti-inﬂammatory
properties (Engels et al., 1992). Currently, apocynin is used as an
inhibitor of the multienzymatic NADPH oxidase complex and
concomitant reactive oxygen species production in experimental
models involving phagocytic cells (Lafeber et al., 1999; Stolk et al.,
1994; Zhang et al., 2005). The mechanism of NADPH oxidase
inhibition by apocynin is not fully understood, but seems to involve
the reduction of p47phox expression and membrane translocation
(Barbieri et al., 2004), inhibition of NF-κB activation and expression,
interference in arachidonic acidmetabolism and reduction of cytokine
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1999; Mazor et al., 2010).
Themultiple side effects of steroidal drugs make the discovery and
development of a safer anti-inﬂammatory drug the goal of many
researchers. Considering the growing evidence of the anti-inﬂammatory
effects of apocynin, and its low cost and toxicity, we aimed to
study the effect of the analogous methoxy-substituted catechol,
4-Fluoro-2-methoxyphenol (F-apocynin). The choice of this com-
pound was based on its structural similarity, but increased hydro-
phobicity compared to apocynin, which could facilitate its penetration
in the cell membrane. On the other hand, the ﬂuorine atom is an
electron-withdrawing group, which is supposed to be important for
the inhibitory effect of apocynin analogous (Kanegae et al., 2007).
These compounds were compared regarding inhibition of reactive
oxygen species production, HOCl production, opsonized microorgan-
ism phagocytosis and tumor necrosis factor-alpha (TNFα) release.
2. Materials and methods
2.1. Chemicals
Apocynin, F-apocynin, 5-ﬂuorotryptamine, catalase, dimethyl
sulfoxide (DMSO), phorbol 12-myristate 13-acetate (PMA), taurine,
dihydrorhodamine 123, paraformaldehyde, zymosan, sodium azide,
3,3,5,5-tetramethylbenzidine (TMB), lucigenin, calcium chloride,
magnesium chloride, glucose, dextran, and RPMI-1640 medium were
purchased from Sigma-Aldrich (St. Louis, MO, USA). Ficoll-Paque was
purchased from GE Healthcare. Myeloperoxidase was purchased from
Planta Natural Products (Vienna, Austria) and Red Blood Cell (RBC)
Lysis Buffer was purchased from eBioscience. FITC-labeled Candida
albicans was provided by Dr. Sônia Jancar and Mariana Morato, and
PI-labeled Staphylococcus aureus was provided by Dr. Alice Maria
Melville Paiva Della. Hydrogen peroxide was prepared by diluting a
30% stock solution and calculating its concentration using its
absorption at 240 nm ( 240 nm=43.6 M–1 cm–1). Hypochlorous acid
was prepared by diluting a concentrated commercial chlorine bleach
solution and calculating its concentration using its absorption at
292 nm ( 292 nm=350 M−1 cm−1). Apocynin and F-apocynin stock
solutions were prepared by dissolving the compounds in dimethyl
sulfoxide (DMSO). Cells incubated with apocynin or F-apocynin were
always compared to cells incubated with the same volume of DMSO
used as vehicle for the drugs (control group). PMA was dissolved in
DMSO at 10 μg/ml. TMB solution was prepared by dissolving 10 mM
TMBand100 μmpotassium iodide in 50%dimethylformamide and50%
acetic acid (400 mM). Human serumopsonized zimosanwas prepared
as described (Brochetta et al. 2003) in a ﬁnal concentration of
10 mg/ml. Brieﬂy, 10 mg of zymosan was suspended in PBS, boiled
for 30 min and washed once with PBS. The pellet was then suspended
in 1.0 ml of human serum pool, kept at 37 °C for 30 min, washed once
with PBS and suspended in 1.0 ml of PBS for a ﬁnal concentration of
10 mg/ml.
2.2. Isolation of human neutrophils and peripheral blood mononuclear
cells
Polymorphonuclear (PMN) and peripheral blood mononuclear cells
were separated by Ficoll-Paque (1.119 and 1.077 g/ml, respectively)
density gradient centrifugation from 20 ml of blood from healthy
donors. After isolation, the cells were resuspended in phosphate
buffered saline (PBS) supplemented with 1.0 mM calcium chloride,
0.5 mM magnesium chloride, and 1.0 mg/ml glucose (supplemented
PBS) or RPMI-1640 supplementedwith 10% fetal bovine serum, 2.0 mM
L-glutamine, 100 U/ml streptomycin and 100 U/ml penicillin for longer
cultureperiods. Flowcytometric assaysweredevelopedwith total blood
or total leukocytes, in which erythrocytes were lysed with RBC lysis
buffer, according to the needs of the evaluation.2.3. Cytotoxicity
Cytotoxicity analysis was performed by Annexin-V/propidium
iodide (PI) assay. Annexin-V and PI staining were performed to
distinguish apoptotic cells from necrotic cells after apocynin or
F-apocynin incubation. Annexin-V has a high afﬁnity for phosphotidyl
serine (PS), which translocates from the inner to the outer leaﬂet of
the plasma membrane at an early stage of apoptosis. Annexin-V was
conjugated with the ﬂuorescent probe FITC, which allowed measure-
ment by ﬂow cytometry. PI staining distinguishes between apoptosis
and necrosis due to the difference in the permeability of PI through
the cell membranes of live and damaged cells. PI is able to emit
ﬂuorescence at ﬂuorescence channel (FL) 2, and is also used in ﬂow
cytometric analysis. Total leukocyteswere incubatedwith apocynin or
F-apocynin (1.0 mM), or with the same volume of the vehicle for 6 h
(control group), and an FITC Annexin V Apoptosis Detection Kit I (BD
Pharmingen) was used to complete the staining (Vassena et al., 2007),
according to the manufacturer's instructions. Fluorescence of gated
PMN was detected in a FACS Canto Flow Cytometer (BD, Franklin
Lakes, NJ, USA). Data was analyzed using the Flowjo Flow Cytometry
Analysis Software (Treestar Inc., Ashlan, OR, USA) and statistical data
were gained from the dot plots based on the proportions of unstained
cells (viable cells), FITC ﬂuorescent-stained cells (apoptotic cells), PI
ﬂuorescent-stained cells and dual stained cells (necrotic cells).
2.4. Determination of hypochlorous acid production by myeloperoxidase
(cell-free system)
The determination of MPO chlorinating activity was based on the
reaction of the produced HOCl with taurine to produce taurine
chloramines, which oxidizes TMB (Malle et al., 2007). The TMB assay
is extremely sensitive and was used to quantitate the production of
HOCl by MPO catalyzed oxidation of chlorine (Malle et al., 2007). The
reactions were performed in a 96-well plate containing PBS, taurine
(5.0 mM), apocynin or F-apocynin (10 or 100 μM, respectively),
puriﬁed MPO (50 nM) and H2O2 (50 μM). The reactions were
triggered by adding H2O2 and incubated at 37 °C. The ﬁnal volume
was 200 μl. After 10 min, the reactions were stopped by adding
catalase (20 μg/ml) and the accumulated taurine chloramine was
measured by adding 50 μl TMB solution. The resulting blue product
was detected spectrophotometrically at 655 nm using a plate reader
(SpectraMax M2, Molecular Devices, Sunnyvale, CA, USA).The
chlorinating inhibitory potency was calculated by accounting for the
amount of taurine chloramine produced in the control, in which the
tested substances were absent.
2.5. Determination of hypochlorous acid production by neutrophils
The determination of hypochlorous acid production by neutrophils
was also based on the reaction of the produced HOCl with taurine to
produce taurine chloramines, which oxidizes TMB (Malle et al., 2007).
The difference in this case is that MPO and H2O2 will be released by
stimulated neutrophils instead of being added to the reaction.
Neutrophils (5.0×106 cells/ml) were preincubated at 37 °C in supple-
mented PBS, containing 5.0 mM taurine and apocynin, F-apocynin or
5-ﬂuorotryptamine (100 or 10 μM, respectively), a compound consid-
ered an excellent inhibitor of MPO (Jantschko et al., 2005) for 10 min.
Next, the cells were stimulated by the addition of PMA (100 nM) or
opsonized zymosan (1.0 mg/ml) and incubated for an additional 30 min
at 37 °C for MPO and H2O2 release. The reactions were stopped by
adding catalase (20 μg/ml) and centrifuged at 2000 rpm. The superna-
tants (200 μl) were transferred to a 96-well plate and 50 μl TMB was
added, as above. The inhibitory potency was calculated by accounting
for the amount of taurine chloramine produced in the control, in which
the cells were incubated in the absence of the tested compounds.
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Lucigenin-dependent chemiluminescence is a sensitive, repro-
ducible and reliable technique for superoxide detection. In this re-
action, superoxide reduces lucigenin to its cation radical, which reacts
with a second superoxide anion to form the energy-rich dioxetane
molecule emitting a photon (Munzel et al., 2002). In our assay, PMN
cells and peripheral blood mononuclear cells (1×106 cells/ml) were
pre-incubated with apocynin or F-apocynin (10 or 100 μM, respec-
tively) for 15 min in supplemented PBS. Next, lucigenin (5.0 μM) and
opsonized zymosan (1.0 mg/ml) were added and the light emission
was measured for 30 min at 37 °C (Centro Microplate Luminometer
LB960, Berthold Technologies, TN, USA). The integrated light emission
was used as an analytical parameter. The inhibitory potency was
calculated by accounting for the light emission generated by the
control, in which the cells were incubated in the absence of the tested
compounds.2.7. Cytometry assay
Dihydrorhodamine 123 (DHR) is largely used in the detection of
intracellular oxidant species production by cell systems. DHR
oxidation by reactive oxygen species results in the formation of
rhodamine, a highly ﬂuorescent component. Total leukocytes were
incubated with apocynin or F-apocynin (1.0 mM) for 2 h and then
stimulated with PMA (400 nM) for 10 min. After PMA stimulation,
cells were incubated with DHR (10 mg/ml) for 5 min, washed once
with PBS and suspended in PBS/BSA/azide buffer (sodium azide 0.1 g,
fetal bovine serum 1.0 ml, PBS q.s.p. 100 ml). Fluorescence of gated
PMN was detected at FL1, counting 30,000 events/gate, in a FACS
Canto Flow Cytometer (BD, Franklin Lakes, NJ, USA). Data was
analyzed using the Flowjo Flow Cytometry Analysis Software
(Treestar Inc., Ashlan, OR, USA) and results were recorded as
ﬂuorescence intensity and percentage of positive cells in the sample.Fig. 1. The molecular structure of apocynin and F-apocynin, and the octanol–water
partition coefﬁcient (logP) calculated using the ChemDraw Ultra® 7.0 software. The
higher the logP, the more hydrophobic the molecule becomes.2.8. Phagocytosis
Phagocytosis assay of S. aureus and C. albicans was performed by
ﬂow cytometry, using microorganisms labeled with FITC (C. albicans)
or PI (S. aureus). C. albicans labeling was performed by incubating the
yeast in carbonate buffer (NaHCO3 840 mg in 100 ml of MilliQ water,
pH 9.5) with FITC (5.0 mg/ml) at 37 °C for 30 min; cells were then
washed twice in carbonate buffer, twice in PBS and stored at−80 °C.
S. aureus labeling with PI was performed using the technique
described by Hasui et al. (1989) with some modiﬁcations; brieﬂy,
the bacteria were suspended in sterile saline solutions and incubated
at 60 °C for 30 min; in the sequence, cells were washed twice in sterile
saline solutions and incubated with propidium iodide (0.1%) for
30 min in the dark; cells were washed twice with sterile saline
solution, suspended in glucose solution (5.0 mMglucose, 0.1% gelatin)
and stored at−80 °C. Phagocytosis assay was performed according to
the method described by White-Owen et al. (1992), with some
modiﬁcations. Brieﬂy, total blood (100 μl) was used to maintain the
serum fraction for pathogen opsonization. Blood of healthy donors
was incubated with apocynin or F-apocynin (1.0 mM) for 2 h and the
cells were allowed to phagocyte labeled microorganisms for 1 h in a
proportion of 10 microorganisms to 1 leukocyte. After this, erythro-
cytes were lysed and leukocytes were ﬁxed in 2% paraformaldehyde.
Fluorescence of gated PMN was detected at FL2 for S. aureus and FL1
for C. albicans in FACS Canto Flow Cytometer (BD, Franklin Lakes, NJ,
USA). As for DHR assay, data was analyzed using the Flowjo Flow
Cytometry Analysis Software (Treestar Inc., Ashlan, OR, USA) and
results were recorded as ﬂuorescence intensity and percentage of
positive cells in the sample.2.9. TNFα release
TNFα, a primary regulator of inﬂammatory responses, was
quantiﬁed in the supernatant of peripheral blood mononuclear cells
and PMN cells of healthy donors incubated with lipopolysaccharide
(LPS — 10 μg/ml) and apocynin or F-apocynin (1.0 mM) for 4 or 24 h
(peripheral blood mononuclear cells only). Cells were cultured in
supplemented RPMI-1640 medium at 37 °C in an atmosphere of 5%
CO2. Cytokine quantiﬁcation was performed by Enzyme-linked
Immunosorbent Assay (ELISA), using a BD OptiEIA Human TNF
ELISA Kit II (Cat. n° 550610), according to the manufacturer's
instructions. Brieﬂy, a monoclonal antibody speciﬁc for TNFα was
coated on a 96-well plate. Dilutions of the TNFα of the standard curve
and the supernatant of cells cultured as mentioned were added to the
wells, and the TNFα present in the sample was allowed to bind to the
immobilized antibody. The wells were washed and a streptavidin–
horseradish peroxidase conjugate mixed with a biotinylated antihu-
man TNFα antibody was added, producing an antibody–antigen–
antibody “sandwich”. The wells were again washed and TMB
substrate solution was added, which produced a blue color in direct
proportion to the amount of TNFα present in the initial sample. The
Stop Solution changed the color from blue to yellow, and color
intensity was detected spectrophotometrically at 450 nm using a
plate reader (SpectraMax plus 384, Molecular Devices, Sunnyvale, CA,
USA).2.10. Statistical analysis
Considering the small size of our samples (nb10), groups were
compared usingMann–Whitney test for independent and asymmetric
samples and results were expressed as median with range. Results
were considered signiﬁcant with a P value b0.05 (Montgomery,
1991).3. Results
3.1. Apocynin versus 4-Fluoro-2-methoxyphenol
The molecular structure of apocynin and F-apocynin is depicted in
Fig. 1. The change of the acetyl group for ﬂuorine was chosen to
maintain the characteristic electron-withdrawing substituent on the
benzene ring, which seems to be important for the inhibitory property
of apocynin (Kanegae et al., 2007), and to increase its lipophilicity,
hence potentially increasing its accessibility to the intracellular
medium. The octanol–water partition coefﬁcient (logP) was calculat-
ed using the ChemDraw Ultra® 7.0 software. LogP is the ratio of the
concentration of a chemical in octanol and in water at equilibrium and
at a speciﬁed temperature. Oil–water partition coefﬁcients in general,
and the octanol–water partition coefﬁcient in particular, are widely
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3.2. Cytotoxicity of apocynin and F-apocynin
Since this was the ﬁrst study evaluating the biological properties of
F-apocynin, the ﬁrst step was to determine whether this chemical
could be cytotoxic at the concentrations used in our experiments.
Therefore, FITC-labeled Annexin-V and PI staining were performed to
distinguish viable cells from apoptotic and necrotic cells by ﬂow
cytometry. At early stages of apoptosis, phosphatidyl serine trans-
locates from the inner to the outer surface of the plasma membrane,
and binds with high afﬁnity to Annexin-V. Conversely, late apoptotic
(or necrotic) cells present increased permeability to PI, and damaged
cells will be stained in red. Our experiments show that neither
apocynin nor F-apocynin (1.0 mM) changed the percentage of either
unstained cells or live cells. Additionally, the percentages of Annexin-V
and PI-labeled PMN cells were not altered by the drugs studied
in comparison to the control group (Fig. 2). In short, neither apocynin
nor F-apocynin was cytotoxic to PMN cells, under the conditions
studied.
3.3. Effect of apocynin and F-apocynin on superoxide production
by leukocytes
We determined and compared the efﬁciencies between apocynin
and F-apocynin as inhibitors of superoxide anion release by
stimulated PMN and peripheral blood mononuclear cells. In this
study, the cells were previously incubated with apocynin or F-Fig. 2. The effect of apocynin and F-apocynin on PMN cell viability determined by Annexin
control group and after 6 h of incubation with apocynin or F-apocynin (1.0 mM) (PN0.05, M
versus PI ﬂuorescence (FL2) is shown in logarithmic scale. Upper left quadrant (PI-stained ce
quadrant (unstained cells) were vital cells, and lower right quadrant (Annexin-V positive and
FITC: ﬂuorescein isothiocyanate, FL: ﬂuorescence channel.apocynin for 15 min and the reaction triggered by adding 10 mg/ml
opsonized zymosan. The production of superoxide anion was
measured by the lucigenin-dependent light emission. The concentra-
tion of lucigenin in the reactionmixture (5 μM)was purposely used to
guarantee the speciﬁcity for detection of superoxide anion released to
the extracellular medium (Munzel et al., 2002). The results in Fig. 3A
show that F-apocynin was signiﬁcantly more effective than apocynin
in both concentrations tested in PMN cells. Similar results were
obtained when peripheral blood mononuclear cells were stimulated
by opsonized zymosan (Fig. 3B).
We also compared the abilities of apocynin and F-apocynin as
inhibitors of intracellular production of reactive oxygen species by
PMN cells assessed by ﬂow cytometry, in which the non-ﬂuorescent
DHR is oxidized by reactive oxygen species giving rise to the
ﬂuorescent rhodamine. As observed in superoxide production,
reactive oxygen species production was also inhibited by F-apocynin
to a higher extent than apocynin, after 2 h of incubation (Fig. 4).
3.4. Effect of apocynin and F-apocynin on the yields of HOCl produced by
isolated MPO and stimulated PMN
The effect of apocynin and F-apocynin on the production of HOCl
through H2O2 mediated oxidation of chloride at physiological levels
and catalyzed by MPO was determined by trapping the produced
HOCl with taurine to form the taurine chloramine, which was assayed
with TMB (Malle et al., 2007). The results depicted in Fig. 5A show that
F-apocynin was also a stronger inhibitor of the chlorinating activity of
MPO than apocynin. In the same way, the inhibitory potency of
F-apocynin was higher compared to apocynin regarding the HOClV/PI ﬂow cytometry. A: Percentage of viable, apoptotic and necrotic PMN cells in the
ann–Whitney test, n=4). B: A dot plot display of Annexin V-FITC ﬂuorescence (FL1)
lls) and upper right quadrant (double stained cells) represented necrotic cells, lower left
PI negative cells) were apoptotic cells. PMN: polymorphonuclear, PI: propidium iodide,
Fig. 3. Inhibition of superoxide production by apocynin or F-apocynin. Peripheral blood mononuclear cells (A) or PMN cells (B) were pre-incubated with 100 or 10 μMof apocynin or
F-apocynin for 15 min and then superoxide production was stimulated by opsonized zymosan. Lucigenin was used as a probe for superoxide detection and light emission was
measured for 30 min at 37 °C. Percentage of inhibition was calculated in comparison to the control group. Data represents at least four experiments (*Pb0.05, Mann–Whitney test).
PMN: polymorphonuclear.
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and C). In fact, the inhibitory effect in the cell systems of both
apocynin and F-apocynin was higher compared to the cell-free
system. This result can be easily explained considering that the cellsFig. 4. The effect of apocynin and F-apocynin on reactive oxygen species production by PMN
stimulated with PMA, and intracellular reactive oxygen species production was determin
production by apocynin or F-apocynin. Percentage of inhibition was calculated in compari
Whitney test). B: A dot plot display of FL1 (green ﬂuorescence) versus side scatter (SSC, tha
cultured with 1.0 mM of apocynin or F-apocynin, or in the absence of the studied compounds
rhodamine-positive cells. The closer the cells were of the left quadrant, the lower was thei
PMN: polymorphonuclear, SSC: side scatter channel, FL: ﬂuorescence channel.were affected in both the production of superoxide anion and the
chlorinating activity of MPO. Speciﬁcally, the inhibitory capacity of
F-apocynin was equivalent to 5-ﬂuorotryptamine, a compound
considered an excellent inhibitor of MPO (Jantschko et al., 2005).cells. PMN cells were pre-incubated with 1.0 mM or 100 μM of apocynin or F-apocynin,
ed by ﬂow cytometry using DHR as a probe. A: Inhibition of reactive oxygen species
son to the control group. Data represents at least four experiments (*Pb0.05, Mann–
t represents cell granularity) is shown in logarithmic scale. In this example, cells were
. Left quadrant represented rhodamine-negative cells, while right quadrant represented
r ﬂuorescence or reactive oxygen species production. PMA: phorbol myristate acetate,
Fig. 5. The effect of apocynin and F-apocynin onMPO chlorinating activity. A: Inhibition
of MPO chlorinating activity by apocynin or F-apocynin (100 or 10 μM, respectively) in
a cell-free system. Apocynin or F-apocynin was incubated in supplemented PBS with
taurine (5.0 mM), puriﬁed MPO (50 mM) and H2O2 (50 μM). HOCl production took
place for 10 min, and reactions were stopped by adding catalase (20 mg/ml) and TMB
was used to detect the accumulated taurine chloramine. B and C: Inhibition of MPO
chlorinating activity by apocynin, F-apocynin or 5-ﬂuorotryptamine (100 or 10 μM,
respectively), a potent inhibitor of MPO activity, in PMN cells. Neutrophils in PBS/
taurine were pre-incubated with apocynin or F-apocynin (100 or 10 μM, respectively)
and MPO release was stimulated by opsonized zymosan (B) or PMA (C). After 30 min,
the reaction was stopped by catalase addition and TMB was added to detect the
accumulated taurine chloramine. Percentage of inhibition was calculated in comparison
to the control group. Data represents at least four experiments (*Pb0.05, Mann–
Whitney test). MPO: myeloperoxidase, PMN: polymorphonuclear, PMA: phorbol
myristate acetate.
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S. aureus
The effects of apocynin and F-apocynin on phagocytosis ability by
PMN leukocytes were determined by ﬂow cytometry using labeledmicroorganisms. Our results showed that F-apocynin and, to a lesser
extent apocynin, signiﬁcantly decrease the ability of PMN cells to
phagocytose C. albicans. Apocynin and F-apocynin decreased the
ﬂuorescence intensity of positive cells, meaning that cells internalized
a smaller number of microorganisms after incubation with the drugs
(Fig. 6), but neither apocynin nor F-apocynin decreased the number of
positive cells in comparison to the control group (data not shown).
The phagocytosis of S. aureuswas also impaired by F-apocynin, but not
by apocynin, although this drug subtly decreased S. aureus phagocy-
tosis by PMN cells (Fig. 6). In contrast to the phagocytosis observed in
C. albicans, F-apocynin decreased ﬂuorescence intensity and the
percentage of S. aureus positive cells. In other words, the drug
decreased the number of PMN cells that are able to phagocytose
S. aureus and the relative number of microorganisms per cell, and,
once again, the inhibition caused by F-apocynin was signiﬁcantly
stronger compared to apocynin (Fig. 6).
3.6. Effect of apocynin and F-apocynin on TNFα release by peripheral
blood mononuclear cells and PMN cells
The release of TNFα by LPS-stimulated PMN and peripheral blood
mononuclear cells incubated with apocynin or F-apocynin was
determined by ELISA. Peripheral blood mononuclear cells were
incubated with apocynin or F-apocynin for 4 and 24 h while PMN
cells, which have shorter life, were cultured for 4 h only. In our
experiments, apocynin and F-apocynin signiﬁcantly inhibited TNFα
release by peripheral blood mononuclear cells in both 4 and 24 h of
culture. However, the drugs had no effect on TNFα release by PMN
cells after 4 h of culture. Different from the previous results, the
inhibition of TNFα observed after incubation with F-apocynin was the
same as observed after incubation with apocynin (Fig. 7).
4. Discussion
The clinical applicability of apocynin as an anti-inﬂammatory drug
has been studied by several groups, which showed that apocynin
efﬁciently decreased signs and symptoms of rheumatoid arthritis,
inﬂammatory bowel disease, atherosclerosis and asthma (Van den
Worm, 2001; Stefanska and Pawliczak, 2008; Pandey et al., 2009; Tang
et al., 2010). Here, we found that the analogous compound F-apocynin
is even more efﬁcient than apocynin at inhibiting NADPH oxidase-
mediated reactive oxygen species generation in neutrophils and
mononuclear cells. This is the ﬁrst work evaluating the anti-
inﬂammatory effects of F-apocynin and its choice was based in its
structural similarity, but increased lipophilicity, compared to apoc-
ynin, which could facilitate the passage of the drug through the cell
membrane. Moreover, in substitution to the acetyl group, the ﬂuorine
atom provides the electron-withdrawing characteristic which seems
important for the mechanism of action of apocynin (Kanegae et al.,
2007). Hence, we propose that a similar working mechanism is
responsible by the inhibitory effects of F-apocynin. An important
point regarding the application of apocynin is its low toxicity,
enabling its use in vivo. Like apocynin, F-apocynin was not cytotoxic
for the cells used here. Therefore, we suggest that F-apocynin will also
be applicable in animal models.
In addition to efﬁciently inhibit the NADPH oxidase system,
F-apocynin signiﬁcantly decreased HOCl production in a cell-free
system and in stimulated PMN. MPO performs a crucial role in the
microbicidal system of neutrophils and monocytes through the
generation of reactive oxidants, in particular HOCl, and radical species
(Van der Veen et al., 2009). In health, MPO-catalyzed formation of
highly reactive halide-derived oxidants is an important component of
the armament of neutrophils and monocytes needed to kill and digest
phagocytosed pathogens (Van der Veen et al., 2009). HOCl, the main
product of the MPO–H2O2–chloride system is a membrane-permeant
potent oxidantwith a broad range of potential targets, including thiols,
Fig. 6. Effect of apocynin and F-apocynin on Candida albicans (A and B) and Staphylococcus aureus (C and D) phagocytosis by PMN cells. Cells were pre-incubated with 1.0 mM of
apocynin or F-apocynin for 2 h, PI-labeled S. aureus or FITC-labeled C. albicans were added, phagocytosis took place for 1 h, and the measurement of S. aureus and C. albicans
phagocytosis by PMN cells was determined by ﬂow cytometry. Fluorescence intensity was used as a parameter of the amount of microorganism ingested by the cells (A and C), and
percentage of inhibition of S. aureus and C. albicans phagocytosis by apocynin or F-apocynin was calculated in comparison to the control group (B and D). Data represents six
experiments (*Pb0.05, Mann–Whitney test). PMN: polymorphonuclear.
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generate chloramines and thereby spawn a wave of toxic species that
have relatively long half-lives and can propagate additional tissue
damage (Nauseef, 2001). In this way, the direct toxic effects of MPO-
derived oxidants, together with its noncatalytic immune-modulating
properties, have been implicated in the induction of malignancies and
tissue injury, as well as in the progression of the inﬂammatory
response in multiple diseases. Speciﬁcally, MPO is directly involved in
the induction and progression of cardiovascular diseases, endothelial
dysfunction (by inhibiting NO), atherosclerosis, carcinogenesis,
neurodegenerative, renal and lung diseases, and chronic inﬂammatory
diseases, such as rheumatoid arthritis and inﬂammatory bowel disease
(Nauseef, 2001; Malle et al., 2007; Van der Veen et al., 2009). Thus, we
conclude that the inhibition of HOCl production after incubation with
F-apocynin and, to a lesser extent, with apocynin, can consequently
decrease the damage induced by these oxidants. Adding to it the
property of inhibiting NADPH oxidase-mediated reactive oxygen
species production, F-apocynin has a great potential to be used as
non-steroidal anti-inﬂammatory drug.
We also compared F-apocynin and apocynin in regard to their
respective capacities to interfere with phagocytosis of opsonized
microorganisms. In contrastwith the literature (Stefanska andPawliczak,
2008), we found that apocynin signiﬁcantly inhibited C. albicans and
S. aureusphagocytosis by PMNcells. In both assays, F-apocyninwasmore
efﬁcient than apocynin in the inhibition of phagocytosis. F-apocynin was
100% more efﬁcient than apocynin in the inhibition of C. albicans
phagocytosis and 45% more efﬁcient in the inhibition of S. aureus
phagocytosis. Stolk et al. (1994) showed that apocynin, in a concentration
of 300 μM, selectively inhibits NADPH oxidase activity but does not
inhibit phagocytosis ability by neutrophils. Our experiments were
developed with a high dose of apocynin and F-apocynin (1.0 mM)
which explains why we observed a reduction in phagocytosis ability.TNFα, a cytokine produced for many cell types, including macro-
phages, neutrophils and keratinocytes, mediates various activities in
different cells (Weinstein and Kirsner, 2010). The effect of apocynin on
TNFα release, along with other cytokines, is well established. For
example, in both in vivo and in vitro assays, apocynin inhibits TNFα
release in cultured peripheral blood mononuclear cells of rheumatoid
arthritis patients (Van denWorm, 2001). Paterniti et al. (2010) showed
that apocynin attenuates TNFα production in the ileum of splanchnic
artery occlusion-shocked rats, and suggested that this effect is a result of
the inhibitory effect of the activation of NF-κB.Using the Sabra ratmodel
of salt-sensitive hypertension, Mazor et al. (2010) showed that
inhibition of NADPH oxidase activity by apocynin is followed by a
reduction in the levels of systemic oxidative stress and TNFα, events
related to the development of hypertension. The authors propose that
the reduction in TNFα release is secondary to the inhibition of oxidative
stress and inﬂammation triggered by the active enzyme. Although the
mechanism by which apocynin inhibits TNFα release is not clear, the
usefulness of this inhibition in the treatment of inﬂammatory diseases is
unquestionable. In agreementwith the literature, apocynin signiﬁcantly
decreased TNFα release by LPS-stimulated peripheral blood mononu-
clear cells in 4 and 24 h of culture, but no effect was observed on LPS-
stimulated PMN cells cultured for 4 h. The same effect was observed
using F-apocynin, which inhibited TNFα release by mononuclear cells
but not by PMN, but, in this case, the F-apocynin effect was comparable
to apocynin, and not stronger. It is interesting tonote that, different than
theobservations in TNFα release experiments, apocynin and F-apocynin
effects on NADPH oxidase and MPO activity are mainly associated with
PMN cells, while little or no effect was observed inmononuclear cells or
monocytes (data not shown).We suggest that themechanism involved
in NADPH oxidase activity inhibition by apocynin, which is MPO-
dependent and, for this reason, more intense in MPO-rich cells, is
different than the mechanism of TNFα release inhibition. In other
Fig. 7. The effect of apocynin and F-apocynin on TNFα release by PMN (A) or peripheral blood mononuclear cells (B and C). A, B and C: Cells were incubated with LPS (10 μg/ml) and
1.0 mM of apocynin or F-apocynin for 4 and 24 h (peripheral blood mononuclear cells only), and TNFα release was quantiﬁed in the supernatant using Enzyme-linked
Immunosorbent Assay (ELISA). D and E: Percentage of inhibition of TNFα release by peripheral blood mononuclear cells incubated with apocynin or F-apocynin for 4 (D) or 24 h (E)
was calculated in comparison to the control group. Data represents seven experiments (*Pb0.05, **Pb0.01, ***Pb0.001, Mann–Whitney test). TNFα: tumor necrosis factor alpha,
PMN: polymorphonuclear.
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seem to be a result of the redox imbalance resulting from NADPH
oxidase activity inhibition. Recently, Dharmarajah et al. (2010) showed
that the anti-platelet actions of apocynin are not the result of an
inhibitory effect on NADPH oxidase or reactive oxygen species
scavenging, as proposed by others (Allen and Bayraktutan, 2008), and
suggested that this effect reinforces the indication of this drugas ananti-
thrombotic agent. It conﬁrms that the effects of apocynin extendbeyond
NADPH oxidase inhibition and consequent redox imbalance.
In summary, owing to the involvement of MPO in the pathophys-
iology of many diseases, several research groups are striving to
develop an effective and safe MPO inhibitor. The same is observed
within the research of NADPH oxidase inhibitors and the search for
more selective and less toxic molecules. In this regard, the efﬁcacy and
lack of toxicity in different in vivo and in vitro assays raised apocynin
to the rank of a lead compound in the search for new, non-steroidal
anti-inﬂammatory compounds. In this work, we have demonstrated
that F-apocynin was more efﬁcient than apocynin in NADPH oxidase,
MPO activity and phagocytosis inhibition. Since F-apocynin exhibits
low toxicity and efﬁciently inhibits reactive oxygen species and HOCl
production and TNFα release, it is a strong candidate for use in the
treatment of inﬂammatory diseases. Additional research is needed to
clearly deﬁne its mechanism.
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